Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Active Ankylosing Spondylitis
NCT05814939Phase 2Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in ankylosing spondylitis (AS), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
VC-005
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT05814939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814939.